ACTIVE STUDIES

Active Studies

Below is a list of our active studies, not including open-label extension studies.

ENROLLMENT OPEN

▾ Adult Adjunctive Major Depressive Disorder

A 3 week, double-blind trial of an NMDA receptor partial agonist add-on investigational medication, compared to add-on placebo, which would be added to an already-approved antidepressant.  Visits are multiple times per week.

https://clinicaltrials.gov/ct2/show/NCT02932943

▾ Adult Adjunctive Major Depressive Disorder

A 52 week, double-blind randomized-withdrawal trial of an atypical antipsychotic add-on investigational medication, compared to add-on placebo, which would be added to an already-approved antidepressant.  Visits are weekly at first then spread out to monthly.

https://clinicaltrials.gov/ct2/show/NCT03560518

▾ Adult Major Depressive Disorder

An 8 week, double-blind trial of an NMDA receptor partial agonist investigational medication, compared to placebo, followed by a 4 month open-label period with only the investigational medication, followed by a 8 month randomized-withdrawal trial comparing the investigational medication to placebo.  Visits are weekly.

https://clinicaltrials.gov/ct2/show/NCT03560518

https://clinicaltrials.gov/ct2/show/NCT03614156

▾ Adolescent Major Depressive Disorder

A 10 week, double-blind trial of an SSRI antidepressant that is already approved in adults, compared to one that is already approved in both adults, children, and adolescents, compared to placebo, followed by a 6 month, open-label trial of the first antidepressant.  Visits are weekly or every other week.

https://clinicaltrials.gov/ct2/show/NCT02372799

https://clinicaltrials.gov/ct2/show/NCT02436239

▾ Adolescent Attention Deficit Hyperactivity Disorder

A 7 or 8 week, double-blind trial of an SSRI antidepressant that is already approved for depression in adults in Europe, but not the United States, compared to placebo, followed by a 3 year, open-label trial.  Visits go from weekly at first to up to every 3 months.

https://clinicaltrials.gov/ct2/show/NCT02436239

https://clinicaltrials.gov/ct2/show/NCT02736656

Apply Now